Showing results (251-260 of 7,880) with videos related to
Sort By:
Pageof 788
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Comparison of human rhabdomyosarcoma, HEp-2, and human foreskin fibroblast cells for the isolation of herpes simplex virus from clinical specimensS L JohnstonDiagnostic Microbiology and Infectious Disease|September 1, 1991
In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501). A quinolone with high activity against gram-positive bacteriaM A Cohen, M D Huband, G B Mailloux, et al.Diagnostic Microbiology and Infectious Disease|April 25, 2006
Antimicrobial activity of tigecycline against recent isolates of respiratory pathogens from Asian countriesKwan Soo Ko, Jae-Hoon Song, Mi Young Lee, et al.Diagnostic Microbiology and Infectious Disease|April 25, 2006
Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA)Paul R Rhomberg, Thomas R Fritsche, Helio S Sader, et al.Diagnostic Microbiology and Infectious Disease|March 21, 2006
Sensitivity of the Enzygnost anti-EBV/IgG for the determination of the Epstein-Barr virus immune status in pediatric patientsMichael Kleines, Simone Scheithauer, Klaus Ritter, et al.Diagnostic Microbiology and Infectious Disease|March 21, 2006
Susceptibility testing practices for Streptococcus pneumoniae: results of a proficiency testing survey of clinical laboratoriesDaniel C Edson, Teri Glick, Laura D MasseyDiagnostic Microbiology and Infectious Disease|August 26, 2006
Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic modelPatrick F Smith, Brian Tsuji, Brent M Booker, et al.Diagnostic Microbiology and Infectious Disease|August 26, 2006
The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococciMarc H Scheetz, Chao Qi, Gary A Noskin, et al.Diagnostic Microbiology and Infectious Disease|August 26, 2006
Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumpsChristine T Ong, Pamela R Tessier, Chonghua Li, et al.Diagnostic Microbiology and Infectious Disease|March 1, 1991
In vitro activity of LY264826 compared to other glycopeptides and daptomycinN X Chin, H C NeuPageof 788